55513-141 : Kanjinti 150 mg/7.15ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 55513-141
Labeler: Amgen Inc
Product Type: Human Prescription Drug
Drug Name:  Kanjinti
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA761073
Rev. Date: 


NDC Package Codes:

  • 55513-141-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (55513‑141‑01) > 7.15 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Trastuzumab

Dosage Strength:

  • 150 mg/7.15mL

Pharmaceutical Classes:

  • HER2/Neu/cerbB2 Antagonists [MoA]
  • HER2/neu Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 55513-132 Kanjinti 420 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Amgen Inc
  • 55513-164 KanjintiKanjinti Kit by Amgen Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-141 QR Code

< Prev: 55513-137Next: 55513-144 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.